Aerobic physical training reduces severe asthma phenotype involving kinins pathway

Mol Biol Rep. 2024 Apr 10;51(1):499. doi: 10.1007/s11033-024-09474-w.

Abstract

Introduction: Aerobic physical training (APT) reduces eosinophilic airway inflammation, but its effects and mechanisms in severe asthma remain unknown.

Methods: An in vitro study employing key cells involved in the pathogenesis of severe asthma, such as freshly isolated human eosinophils, neutrophils, and bronchial epithelial cell lineage (BEAS-2B) and lung fibroblasts (MRC-5 cells), was conducted. Additionally, an in vivo study using male C57Bl/6 mice, including Control (Co; n = 10), Trained (Exe; n = 10), house dust mite (HDM; n = 10), and HDM + Trained (HDM + Exe; n = 10) groups, was carried out, with APT performed at moderate intensity, 5x/week, for 4 weeks.

Results: HDM and bradykinin, either alone or in combination, induced hyperactivation in human neutrophils, eosinophils, BEAS-2B, and MRC-5 cells. In contrast, IL-10, the primary anti-inflammatory molecule released during APT, inhibited these inflammatory effects, as evidenced by the suppression of numerous cytokines and reduced mRNA expression of the B1 receptor and ACE-2. The in vivo study demonstrated that APT decreased bronchoalveolar lavage levels of bradykinin, IL-1β, IL-4, IL-5, IL-17, IL-33, TNF-α, and IL-13, while increasing levels of IL-10, klotho, and IL-1RA. APT reduced the accumulation of polymorphonuclear cells, lymphocytes, and macrophages in the peribronchial space, as well as collagen fiber accumulation, epithelial thickness, and mucus accumulation. Furthermore, APT lowered the expression of the B1 receptor and ACE-2 in lung tissue and reduced bradykinin levels in the lung tissue homogenate compared to the HDM group. It also improved airway resistance, tissue resistance, and tissue damping. On a systemic level, APT reduced total leukocytes, eosinophils, neutrophils, basophils, lymphocytes, and monocytes in the blood, as well as plasma levels of IL-1β, IL-4, IL-5, IL-17, TNF-α, and IL-33, while elevating the levels of IL-10 and IL-1RA.

Conclusion: These findings indicate that APT inhibits the severe asthma phenotype by targeting kinin signaling.

Keywords: Bradykinin; Exercise immunology; Pulmonary rehabilitation; STAT signaling; Severe asthma.

MeSH terms

  • Animals
  • Asthma*
  • Bradykinin*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-10
  • Interleukin-17
  • Interleukin-33
  • Interleukin-4
  • Interleukin-5
  • Male
  • Mice
  • Tumor Necrosis Factor-alpha

Substances

  • Bradykinin
  • Interleukin-10
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-17
  • Interleukin-33
  • Interleukin-4
  • Interleukin-5
  • Tumor Necrosis Factor-alpha